Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Costs and cost‐driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany
Lena‐Marie Kortland, Anne Alfter, Oliver Bähr, et al.
Epilepsia (2016) Vol. 57, Iss. 12, pp. 2056-2066
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

25 years of advances in the definition, classification and treatment of status epilepticus
Eugen Trinka, Reetta Kälviäinen
Seizure (2016) Vol. 44, pp. 65-73
Closed Access | Times Cited: 203
Costs, length of stay, and mortality of super‐refractory status epilepticus: A population‐based study from Germany
Adam Strzelczyk, Sonja Ansorge, Jana Hapfelmeier, et al.
Epilepsia (2017) Vol. 58, Iss. 9, pp. 1533-1541
Open Access | Times Cited: 178
Lacosamide in status epilepticus: Systematic review of current evidence
Adam Strzelczyk, Johann Philipp Zöllner, Laurent M. Willems, et al.
Epilepsia (2017) Vol. 58, Iss. 6, pp. 933-950
Open Access | Times Cited: 125
The Burden of Severely Drug-Refractory Epilepsy: A Comparative Longitudinal Evaluation of Mortality, Morbidity, Resource Use, and Cost Using German Health Insurance Data
Adam Strzelczyk, Claudia Griebel, Wolfram Lux, et al.
Frontiers in Neurology (2017) Vol. 8
Open Access | Times Cited: 125
Long‐term outcomes of status epilepticus: A critical assessment
Claudine Sculier, Marina Gaínza‐Lein, Iván Sánchez Fernández, et al.
Epilepsia (2018) Vol. 59, Iss. S2, pp. 155-169
Open Access | Times Cited: 119
Factors predicting cessation of status epilepticus in clinical practice: Data from a prospective observational registry (SENSE)
Christoph Kellinghaus, Andrea O. Rossetti, Eugen Trinka, et al.
Annals of Neurology (2019) Vol. 85, Iss. 3, pp. 421-432
Open Access | Times Cited: 113
Change in Mortality of Generalized Convulsive Status Epilepticus in High-Income Countries Over Time
Aidan Neligan, Alastair Noyce, Tushar Divakar Gosavi, et al.
JAMA Neurology (2019) Vol. 76, Iss. 8, pp. 897-897
Open Access | Times Cited: 96
Vagus nerve stimulation in refractory and super-refractory status epilepticus – A systematic review
Maxine Dibué, Francesco Brigo, Takamichi Yamamoto, et al.
Brain stimulation (2019) Vol. 12, Iss. 5, pp. 1101-1110
Open Access | Times Cited: 75
Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitals
Adam Strzelczyk, Isabel Steinig, Laurent M. Willems, et al.
Epilepsy & Behavior (2017) Vol. 70, pp. 177-181
Closed Access | Times Cited: 73
Burden and epidemiology of status epilepticus in infants, children, and adolescents: A population‐based study on German health insurance data
Susanne Schubert‐Bast, Johann Philipp Zöllner, Sonja Ansorge, et al.
Epilepsia (2019) Vol. 60, Iss. 5, pp. 911-920
Closed Access | Times Cited: 68
Incidence, Risk Factors and Consequences of Epilepsy-Related Injuries and Accidents: A Retrospective, Single Center Study
Laurent M. Willems, Nina Watermann, Saskia Richter, et al.
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 65
Association Between Treatment Progression, Disease Refractoriness, and Burden of Illness Among Hospitalized Patients With Status Epilepticus
Elan L. Guterman, John P. Betjemann, Alex A. Aimetti, et al.
JAMA Neurology (2021) Vol. 78, Iss. 5, pp. 588-588
Open Access | Times Cited: 49
Intravenous ganaxolone for the treatment of refractory status epilepticus: Results from an open‐label, dose‐finding, phase 2 trial
Henrikas Vaitkevicius, R. Eugene Ramsay, Christa B. Swisher, et al.
Epilepsia (2022) Vol. 63, Iss. 9, pp. 2381-2391
Open Access | Times Cited: 35
Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020
Maja Hochbaum, Ricardo Kienitz, Felix Rosenow, et al.
Epilepsy & Behavior (2022) Vol. 130, pp. 108666-108666
Closed Access | Times Cited: 33
Outcomes and Treatment Approaches for Super-Refractory Status Epilepticus
Camilla Dyremose Cornwall, Thomas Krøigård, Joachim Sejr Skovbo Kristensen, et al.
JAMA Neurology (2023) Vol. 80, Iss. 9, pp. 959-959
Open Access | Times Cited: 17
Autoimmune encephalitis
Jesse Cohen, Javier Sotoca, Shikha Gandhi, et al.
Neurology (2019) Vol. 92, Iss. 9
Closed Access | Times Cited: 53
Duration of therapeutic coma and outcome of refractory status epilepticus
Wolfgang Mühlhofer, Stephen Layfield, Daniel H. Lowenstein, et al.
Epilepsia (2019) Vol. 60, Iss. 5, pp. 921-934
Open Access | Times Cited: 52
Treatment of refractory and superrefractory status epilepticus with topiramate: A cohort study of 106 patients and a review of the literature
Anne Fechner, Kristina Hubert, Kolja Jahnke, et al.
Epilepsia (2019) Vol. 60, Iss. 12, pp. 2448-2458
Open Access | Times Cited: 44
Multicenter, cross‐sectional study of the costs of illness and cost‐driving factors in adult patients with epilepsy
Laurent M. Willems, Maja Hochbaum, Katharina Frey, et al.
Epilepsia (2022) Vol. 63, Iss. 4, pp. 904-918
Open Access | Times Cited: 27
Epidemiology, real-world treatment and mortality of patients with status epilepticus in Germany: insights from a large healthcare database
Antje Mevius, Lars Joeres, P Gille, et al.
Brain Communications (2023) Vol. 5, Iss. 3
Open Access | Times Cited: 15
Status epilepticus in patients with brain tumors and metastases: A multicenter cohort study of 208 patients and literature review
Johanna K Rickel, Daria Zeeb, Susanne Knake, et al.
Neurological Research and Practice (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 5
Socioeconomic Outcome and Quality of Life in Adults after Status Epilepticus: A Multicenter, Longitudinal, Matched Case–Control Analysis from Germany
Lena‐Marie Kortland, Susanne Knake, Felix von Podewils, et al.
Frontiers in Neurology (2017) Vol. 8
Open Access | Times Cited: 42
The role of AMPA receptors and their antagonists in status epilepticus
Antonio Leo, Giada Giovannini, Emilio Russo, et al.
Epilepsia (2018) Vol. 59, Iss. 6, pp. 1098-1108
Open Access | Times Cited: 41
How much refractory is ‘refractory status epilepticus’? A retrospective study of treatment strategies and clinical outcomes
Simona Lattanzi, Giada Giovannini, Niccolò Orlandi, et al.
Journal of Neurology (2023) Vol. 270, Iss. 12, pp. 6133-6140
Closed Access | Times Cited: 12
Burden of status epilepticus: prognosis and cost driving factors, insight from a nationwide retrospective cohort study of the French health insurance database
Quentin Calonge, François Le Gac, Mario Chávez, et al.
Journal of Neurology (2024) Vol. 271, Iss. 10, pp. 6761-6772
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top